Retrospective study of teicoplanin loading regimen that rapidly achieves target 15-30 μg/mL serum trough...

Area of Science:

• Pharmacology
• Infectious Diseases
• Clinical Pharmacy

Background:

• Teicoplanin is an antibiotic used to treat serious bacterial infections.
• Determining the optimal loading dose for teicoplanin is crucial for achieving therapeutic concentrations and improving efficacy.
• Previous studies have not definitively established the ideal loading dose regimen.

Purpose of the Study:

• To evaluate the probability of achieving target teicoplanin concentrations (15-30 μg/mL) within three days of therapy initiation.
• To compare the clinical efficacy and safety of different teicoplanin loading dose regimens.
• To identify the optimal loading dose for early therapeutic success.

Main Methods:

• A retrospective study involving 42 patients treated with teicoplanin.
• Patients were divided into three groups based on their loading dose: 40 mg/kg (Group 1), 35 mg/kg (Group 2), and 30 mg/kg (Group 3), all administered for two days.
• Outcomes measured included the proportion of patients achieving target teicoplanin concentrations, clinical efficacy, and incidence of hepatotoxicity and nephrotoxicity.

Main Results:

• Group 1 (40 mg/kg) achieved 100% target concentration, compared to 57.9% in Group 2 (35 mg/kg) and 38.9% in Group 3 (30 mg/kg) (p=0.05).
• No significant differences in hepatotoxicity or nephrotoxicity were observed among the groups.
• While overall clinical efficacy was similar, Groups 1 and 2 showed significantly lower CRP levels 4-7 days post-therapy compared to Group 3.

Conclusions:

• A teicoplanin loading dose of 35-40 mg/kg for two days is recommended for achieving target concentrations earlier.
• This higher loading dose regimen may contribute to improved infection management.
• The safety profile of the higher loading doses was comparable to the standard regimen.